Search Results - "Farrokhi, Catherine"

Refine Results
  1. 1

    Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse by Currais, Antonio, Farrokhi, Catherine, Dargusch, Richard, Armando, Aaron, Quehenberger, Oswald, Schubert, David, Maher, Pamela

    “…Alzheimer's disease (AD) is rarely addressed in the context of aging even though there is an overlap in pathology. We previously used a phenotypic screening…”
    Get full text
    Journal Article
  2. 2

    Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model by Xu, Jiqing, de Winter, Fred, Farrokhi, Catherine, Rockenstein, Edward, Mante, Michael, Adame, Anthony, Cook, Jonathan, Jin, Xin, Masliah, Eliezer, Lee, Kuo-Fen

    Published in Scientific reports (25-08-2016)
    “…Several lines of evidence suggest that neuregulin 1 (NRG1) signaling may influence cognitive function and neuropathology in Alzheimer’s disease (AD). To test…”
    Get full text
    Journal Article
  3. 3

    A comprehensive multiomics approach toward understanding the relationship between aging and dementia by Currais, Antonio, Goldberg, Joshua, Farrokhi, Catherine, Chang, Max, Prior, Marguerite, Dargusch, Richard, Daugherty, Daniel, Armando, Aaron, Quehenberger, Oswald, Maher, Pamela, Schubert, David

    Published in Aging (Albany, NY.) (11-11-2015)
    “…Because age is the greatest risk factor for sporadic Alzheimer's disease (AD), phenotypic screens based upon old age-associated brain toxicities were used to…”
    Get full text
    Journal Article
  4. 4

    Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus by Pechnick, Robert N, Zonis, Svetlana, Wawrowsky, Kolja, Cosgayon, Rosemarie, Farrokhi, Catherine, Lacayo, Liliana, Chesnokova, Vera

    Published in PloS one (04-11-2011)
    “…The relationships among hippocampal neurogenesis, depression and the mechanism of action of antidepressant drugs have generated a considerable amount of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety by Candolfi, Marianela, Kroeger, Kurt M, Muhammad, A K M G, Yagiz, Kader, Farrokhi, Catherine, Pechnick, Robert N, Lowenstein, Pedro R, Castro, Maria G

    Published in Current gene therapy (01-10-2009)
    “…Glioblastoma multiforme (GBM) is the most common primary brain cancer in adults. Despite significant advances in treatment and intensive research, the…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice by Tovote, Philip, Farrokhi, Catherine Borna, Gonzales, Rachael M.K, Schnitzbauer, Udo, Blanchard, D. Caroline, Blanchard, Robert J, Spiess, Joachim

    Published in Psychoneuroendocrinology (01-07-2010)
    “…Summary CRF receptor subtype 1 (CRF1), abundantly expressed in the central nervous system, has been implicated in defensive behavior in rodents…”
    Get full text
    Journal Article
  9. 9

    Effects of the CRF1 antagonist SSR125543A on aggressive behaviors in hamsters by Farrokhi, Catherine, Blanchard, D.Caroline, Griebel, Guy, Yang, Mu, Gonzales, Coty, Markham, Chris, Blanchard, Robert J.

    Published in Pharmacology, biochemistry and behavior (01-03-2004)
    “…Corticotropin-releasing factor (CRF) and its receptor subtypes have been implicated in endocrine and behavioral responsivity to stress and emotion, including…”
    Get full text
    Journal Article
  10. 10

    Depletion of Brain Perivascular Macrophages Mitigates Depressive‐like Behavioral Consequences of Chronic Mild Stress by Grigoleit, Jan‐Sebastian, Alvarez, Elena, Farrokhi, Catherine Borna, Sawchenko, Paul E.

    Published in The FASEB journal (01-04-2016)
    “…Abstract only Despite intensive research, the etiology of depression remains poorly understood. Stress is implicated in the pathogenesis of most depressive…”
    Get full text
    Journal Article
  11. 11

    Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discovery by Prior, Marguerite, Goldberg, Joshua, Chiruta, Chandramouli, Farrokhi, Catherine, Kopynets, Mariya, Roberts, Amanda J., Schubert, David

    Published in Alzheimer's & dementia (01-06-2016)
    “…Neurons die in Alzheimer's disease (AD) and are not effectively replaced. An alternative approach to maintain nerve cell number is to identify compounds that…”
    Get full text
    Journal Article
  12. 12

    Selecting for neurogenic potential as an alternative for Alzheimer's drug discovery by Prior, Marguerite, Goldberg, Joshua, Chiruta, Chandramouli, Farrokhi, Catherine, Kopynets, Mariya, Roberts, Amanda J, Schubert, David

    Published in Alzheimer's & dementia (02-05-2016)
    “…Abstract Introduction Neurons die in Alzheimer's disease (AD) and are not effectively replaced. An alternative approach to maintain nerve cell number is to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters by BLANCHARD, Robert J, GRIEBEL, Guy, FARROKHI, Catherine, MARKHAM, Chris, MU YANG, BLANCHARD, D. Caroline

    “…Arginine vasopressin (AVP) has been implicated in a variety of physiological and behavioral responses to stress. Synthesis of receptor-selective AVP agonist…”
    Get full text
    Journal Article
  15. 15

    Cognitive impairment and decreased hippocampal neurogenesis after treatment with chemotherapeutic drugs by Pechnick, Robert N, Reyes, Kevin C, Das, Melanie, Lacayo, Liliana M, Farrokhi, Catherine, Zonis, Svetlana, Chesnokova, Vera

    Published in The FASEB journal (01-04-2010)
    “…Post‐chemotherapy cognitive impairment has long been recognized in cancer survivors; however, at the present time the cause(s) is not known. The objective of…”
    Get full text
    Journal Article
  16. 16

    Age‐dependent differences in antidepressant response by Lacayo, Liliana Margarita, Farrokhi, Catherine, Manalo, Charlene M, Reyes, Kevin C, Pechnick, Robert N

    Published in The FASEB journal (01-04-2009)
    “…Abstract only The efficacy of tricyclic antidepressant treatment in children and adolescents is highly controversial. This investigation examined potential…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats by Pechnick, Robert N, Manalo, Charlene M, Lacayo, Liliana M, Vit, Jean-Philippe, Bholat, Yasmin, Spivak, Inna, Reyes, Kevin C, Farrokhi, Catherine

    Published in Behavioural pharmacology (01-06-2011)
    “…Acamprosate is used in the treatment of alcoholism; however, there is little information on its effects on nicotine addiction. The objective of this study was…”
    Get full text
    Journal Article
  20. 20

    Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB) by Yang, Mu, Farrokhi, Catherine, Vasconcellos, Amy, Blanchard, Robert J., Blanchard, D. Caroline

    Published in Behavioural brain research (15-07-2006)
    “…Following intracerebroventricular (i.c.v.) injection of ovine CRF (oCRF), an endogenous peptide agonist at both CRF1 and CRF2 receptors, defensive behaviors of…”
    Get full text
    Journal Article